XPH ETF (State Street SPDR S&P Pharmaceuticals ETF) is managed by State Street Investment Management with $471.7M in net assets. XPH expense ratio is 0.35%, holding 61 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-06-19.

XPH performance shows a YTD return of 24.41%. The 1-year return is 64.74% and the 5-year return is 6.43%. XPH dividend yield stands at 0.51%, paid quarterly.

XPH top holdings include Organon & Co (3.7%), Corcept Therapeutics Inc (2.5%), Enliven Therapeutics Inc (2.4%), Axsome Therapeutics, Inc (2.3%), Omers (2.2%). View all XPH holdings, sector breakdown, or dividend history.

XPH can be compared against other funds using the overlap calculator or side-by-side comparison tool. XPH alternatives are available via the screener, along with tax-loss harvesting opportunities.